Bildkälla: Stockfoto

CLS Q3’21: Progressing According to Plan - Redeye

Redeye gives its view on CLS' Q3’21 report as well as yesterday’s news regarding the relaunch of its sterile disposable products in the US. We maintain our positive long-term view and reiterate our Base Case.

Redeye gives its view on CLS' Q3’21 report as well as yesterday’s news regarding the relaunch of its sterile disposable products in the US. We maintain our positive long-term view and reiterate our Base Case.
Börsvärldens nyhetsbrev
ANNONSER